MeSH term
Frequency | Condition_Probility | Adult | 42 | 0.0 |
Aged | 5 | 0.0 |
Female | 35 | 0.0 |
Humans | 86 | 0.0 |
Male | 40 | 0.0 |
Middle Aged | 16 | 0.0 |
Animals | 25 | 0.0 |
Dopamine/*metabolism | 2 | 1.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 6 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 41 | 0.0 |
Brain Mapping/*methods | 3 | 12.0 |
Comparative Study | 11 | 0.0 |
Laterality | 3 | 5.0 |
Magnetic Resonance Imaging | 10 | 0.0 |
Memory/*physiology | 9 | 14.0 |
Prefrontal Cortex/*physiology | 18 | 69.0 |
Reading | 3 | 25.0 |
Research Support, Non-U.S. Gov't | 52 | 0.0 |
Laterality/physiology | 2 | 3.0 |
Rats | 5 | 0.0 |
Adolescent | 11 | 0.0 |
Brain Mapping | 10 | 7.0 |
Discrimination Learning/physiology | 2 | 66.0 |
*Magnetic Resonance Imaging | 8 | 4.0 |
Neuropsychological Tests | 6 | 2.0 |
Pattern Recognition, Visual/physiology | 4 | 30.0 |
Reaction Time/physiology | 6 | 6.0 |
Aging/*physiology | 2 | 0.0 |
Attention/physiology | 4 | 13.0 |
Image Processing, Computer-Assisted | 3 | 0.0 |
Mental Recall/*physiology | 4 | 30.0 |
Body Weight | 2 | 0.0 |
Dominance, Cerebral/physiology | 2 | 7.0 |
Reference Values | 4 | 0.0 |
*Disease Models, Animal | 3 | 0.0 |
*Schizophrenic Psychology | 2 | 3.0 |
Task Performance and Analysis | 2 | 6.0 |
Analysis of Variance | 4 | 0.0 |
Magnetic Resonance Imaging/methods | 3 | 3.0 |
Memory, Short-Term/*physiology | 4 | 33.0 |
Photic Stimulation/methods | 2 | 8.0 |
Time Factors | 4 | 0.0 |
Age Factors | 2 | 0.0 |
Estradiol/*administration & dosage | 2 | 16.0 |
Prefrontal Cortex/physiology | 3 | 60.0 |
Progesterone/*administration & dosage | 2 | 66.0 |
Evoked Potentials/physiology | 3 | 10.0 |
Cognition/physiology | 5 | 15.0 |
Mental Recall/physiology | 2 | 18.0 |
Reaction Time | 4 | 3.0 |
Retention (Psychology)/physiology | 2 | 50.0 |
Attention/*physiology | 2 | 4.0 |
Memory/physiology | 2 | 6.0 |
Photic Stimulation | 4 | 6.0 |
Psychomotor Performance/physiology | 6 | 13.0 |
Tomography, Emission-Computed | 3 | 2.0 |
Models, Neurological | 2 | 1.0 |
Cognition/*physiology | 3 | 4.0 |
Evoked Potentials/*physiology | 2 | 10.0 |
English Abstract | 2 | 0.0 |
Laterality/*physiology | 2 | 6.0 |
Immunoglobulin G/blood | 2 | 0.0 |
Emulsions | 2 | 2.0 |
Prospective Studies | 2 | 0.0 |
Evaluation Studies | 2 | 0.0 |
Infant, Newborn | 3 | 0.0 |
Random Allocation | 2 | 0.0 |
Child | 4 | 0.0 |
Child, Preschool | 2 | 0.0 |
Arousal/physiology | 2 | 9.0 |
Dopamine/*physiology | 2 | 2.0 |
Learning/physiology | 2 | 13.0 |
*Models, Biological | 2 | 1.0 |
Mental Processes/*physiology | 2 | 15.0 |
Problem Solving/physiology | 2 | 22.0 |
Antibody-Producing Cells/*drug effects | 2 | 66.0 |
Dose-Response Relationship, Drug | 5 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Serial Learning/*physiology | 2 | 100.0 |
Chromosome Mapping | 4 | 0.0 |
Linkage (Genetics) | 3 | 0.0 |
Pedigree | 3 | 0.0 |
*X Chromosome | 4 | 0.0 |
Base Sequence | 2 | 0.0 |
Molecular Sequence Data | 2 | 0.0 |
Brain/*physiology | 2 | 1.0 |
Properdin/*genetics | 2 | 50.0 |
Mice | 8 | 0.0 |
Kinetics | 7 | 0.0 |
Antibody-Producing Cells | 2 | 100.0 |
Cells, Cultured | 5 | 0.0 |
Erythrocytes/immunology | 4 | 1.0 |
Herpesvirus 4, Human | 2 | 1.0 |
In Vitro | 4 | 0.0 |
Lymphocytes/*immunology | 4 | 0.0 |
Spleen/immunology | 2 | 1.0 |
Mice, Inbred ICR | 2 | 0.0 |
Serum Albumin/metabolism | 2 | 1.0 |
Thyrotropin/pharmacology | 2 | 3.0 |
Thyroxine/blood | 2 | 0.0 |
Triiodothyronine/blood | 2 | 0.0 |
Triiodothyronine, Reverse/blood | 2 | 7.0 |
Hemolytic Plaque Technique | 13 | 21.0 |
Immunoglobulins/biosynthesis | 3 | 2.0 |
Dose-Response Relationship, Immunologic | 2 | 0.0 |
*Antibody Formation | 2 | 2.0 |
Antibody-Producing Cells/immunology | 3 | 12.0 |
Antigen-Antibody Reactions | 2 | 0.0 |
Antigens/*immunology | 2 | 2.0 |
T-Lymphocytes/immunology | 4 | 0.0 |
Pokeweed Mitogens/pharmacology | 4 | 5.0 |
Lymphocyte Activation | 5 | 0.0 |
T-Lymphocytes/*immunology | 2 | 0.0 |
T-Lymphocytes, Helper-Inducer/immunology | 2 | 1.0 |
Immunoglobulins/*biosynthesis | 3 | 6.0 |
*Immunosuppression | 2 | 2.0 |
Leukocyte Count | 3 | 0.0 |
B-Lymphocytes/immunology | 6 | 0.0 |
*Lymphocyte Activation | 5 | 0.0 |
B-Lymphocytes/*immunology | 5 | 0.0 |
Clone Cells/immunology | 2 | 1.0 |
Antibody-Producing Cells/*immunology | 4 | 25.0 |
Immunoglobulin G/biosynthesis | 3 | 1.0 |
Fetal Blood/*immunology | 2 | 2.0 |
Staphylococcus aureus/*immunology | 2 | 2.0 |
Antibody Formation | 3 | 0.0 |
Immunoglobulins/*secretion | 2 | 100.0 |
*Hemolytic Plaque Technique | 4 | 44.0 |
Antibody Formation/*drug effects | 2 | 10.0 |
Immunoglobulin M/biosynthesis | 2 | 2.0 |
